Toei Shinyaku Co., Ltd. (Headquarters: Mitaka, Tokyo; President & CEO: Akitomo Motoi) is pleased to announce that it has obtained a patent related to the improvement of stress-induced cognitive impairment through the intake of King Agaricus KA21.
This patent was granted based on research conducted jointly with Shigakkan Educational Foundation, including Shigakkan University (Location: Obu, Aichi Prefecture; Co-researcher: Professor Takanori Tada, Faculty of Health Science).
Press Release
Japanese：https://www.atpress.ne.jp/news/550551
English：https://en.atpress.com/news/550551
Chinese：https://zh.atpress.com/news/550551
Patent Details
-
Patent Number: JP Patent No. 7752340
-
Patent Application Number: JP 2022-174395
-
Filing Date: October 31, 2022
-
Registration Date: October 2, 2025
-
Inventors: Takanori Tada, Akitomo Motoi
-
Applicants: Toei Shinyaku Co., Ltd.; Shigakkan Educational Foundation
This patent covers the use of King Agaricus KA21 for improving cognitive dysfunction caused by stress, supporting its potential application in the fields of anti-aging, mental wellness, and cognitive health.
Toei Shinyaku Co., Ltd. will continue to advance science-based functional ingredients through academic collaboration and intellectual property development, contributing to human health and quality of life.